Drug Allergy, Insect Allergy, and Vaccines Courses
|Virtual Patient: Drug Allergy in Older Adults||
|Mining the Electronic Health Record for Delayed Hypersensitivity Phenotypes||
|Ex vivo/ In vitro Testing for Delayed Drug Hypersensitivity||
2023 AAAAI Annual Meeting - Virtual Content Available
The 2023 AAAAI Annual Meeting is available for virtual participation through December 31, 2023. Visit the Annual Meeting website to register and access the virtual content.
Sessions on Drug Allergy, Insect Allergy, and Vaccines include:
1526 Tackling Vaccine Hesitancy in Adults, Children and Special Populations
1601 Presidential Plenary: Paradigm Shifts in Drug Allergy
2305 Allergy to COVID-19 Vaccines and COVID-19 Therapeutics
2808 The Ins and Outs of Severe Cutaneous Adverse Reactions (SCARs)
3304 Using Drug Allergy Expertise to Improve Patient Care in Other Specialties
4303 Mechanisms of Immediate Drug-Induced Hypersensitivity Reaction
4305 Technology and the Electronic Health Record in Allergy
4712 Drug Allergy: Going Beyond Penicillin Allergy
5001 Diagnostic Testing in Insect Allergy
5003 Toxicities of Immune Checkpoint Inhibitors: Part 1
5005 Pearls for Communication: How to Discuss Drug Allergy with Our Non-Allergist Colleagues
5006 Diverse Hypersensitivity Reactions Associated with Vancomycin
5205 Vaccination and the Allergist/Immunologist
5401 Drug Allergy: Other Drugs
5402 Update on Allergy to Non-Beta-Lactam Antibiotics
5405 Drug Allergy Practice Parameter Update
5407 Evaluation and Management of Reactions to Novel Therapeutics for the Allergist
Drug Allergy, Insect Allergy, and Vaccines Resources for Healthcare Providers
AAAAI/ACAAI Joint Venom Extract Shortage Task Force Report (2017)
Anaphylaxis Action Plan
Penicillin Allergy Toolbox - This special site includes a variety of patient and provider resources related to the diagnosis and management of patients with a penicillin allergy.
Drug Allergy and Insect Allergy resources, including an overview, explanation of symptoms and diagnosis, treatment and management, an action plan, information for patients, and more.
AAAAI Statements and Practice Parameters reflect the most current guidance available from the AAAAI on clinical topics related to allergies, asthma and immunologic disease.
Collaborate with Drug Allergy Professionals
Interested in collaborating with fellow AAAAI members who share a particular interest in Drug Allergy? The ADDA Interest Section is the community for AAAAI members interested in advancing the knowledge and understanding of food allergy diagnosis and treatment. Topics covered include: anaphylaxis, dermatology, and drug allergy.
To learn more about the work of this interest section, contact one of the leaders below:
Vice Chair: Miguel A. Park, MD FAAAAI
Secretary: Peck Y. Ong, MD FAAAAI
Staff Liaison: Lauri Sweetman
Interested in aligning with ADDA?
Becoming part of the ADDA community network is as simple as linking to your AAAAI personal member profiles and updating your profile to reflect your primary membership as ADDA under the tab labeled Involvement.
Or, consider the work of the Allergic Skin Diseases Committee. Its purpose is to facilitate education and research activities in advancing knowledge and improving care for atopic dermatitis, urticaria, angioedema, contact dermatitis and other related immune-mediated skin diseases. . NOTE: Interest Section Committees are open to all members of the AAAAI.